CMMB vs LABT (Chemomab Therapeutics Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 28 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 6:07 PM ET. All metrics below represent finalized session performance.
CMMB leads by +12.38% Alpha Spread Today
CMMB is trading at +1.83% while LABT is at -10.55% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | CMMB | LABT | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +1.83% | -10.55% | CMMB +12.38% |
| Net Dollar Move | +$0.03 | $-0.21 | CMMB higher move |
| Open Price | $1.59 | $1.97 | Gap: -3.05% vs -1.01% |
| Day High | $1.77 | $2.00 | Session peaks |
| Day Low | $1.50 | $1.78 | Session troughs |
| Intraday Spread | $0.27 | $0.22 | High/Low spread |
| Share Volume | 221.7K | 109.8K | CMMB more active |
| Est. Dollar Volume | $370.2K | $195.4K | CMMB higher liquidity |
Explore CMMB vs LABT Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.